Skip to content

Financing and HSA/FSA

altRx vs SnagRx: Financing and HSA/FSA Compared (2026)

Compare altRx and SnagRx on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.

Published · Pricing as published in our provider dataset, synced · Editorial scores 8.4 and 7.5 out of 10

We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.

Two platforms, one drug class, and a difference in annual cost most people do not notice until month four. That is the altRx versus SnagRx question.

Neither of these bills insurance, so the financing question is a real one. altRx supports Affirm, Klarna and Afterpay, while SnagRx expects the card to clear each month.

What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Undisclosed pricing is treated as a finding, not rounded into an estimate.

The short answer

Lowest 12-month cost
SnagRx$828 against $1,068 at altRx, on each provider's own best published pricing.
Most predictable bill
altRxFlat rate at every dose, so titration does not change what you are charged.
Fastest route to a first shipment
SnagRx5-minute intake, clinician review typically within 5 hours and always within 24, then free next-day UPS or FedEx in temperature-controlled packaging.
Most support included
altRxResponsive care team for ongoing clinician-guided support.

Side-by-side comparison

Every figure below is the provider's own published number. The blank spaces are theirs, not ours.

 altRxSnagRx
Advertised priceSemaglutide $89/mo, tirzepatide $149/moSemaglutide $99/mo month-to-month, or $69/mo on the 12-month plan
Rate after promotions$89/mo$99/mo
Pricing structureFlat rate at every doseFlat rate at every dose
MedicationCompounded semaglutide and compounded tirzepatideCompounded semaglutide and compounded tirzepatide
Payment optionsAffirm, Klarna and AfterpayCard only, no financing published
State coverageNot available in every state48 states
How fast you start100% online medical visits5-minute intake, clinician review typically within 5 hours and always within 24
Membership feeNoneNone
ShippingFree, discreet 2-day deliveryFree next-day UPS or FedEx in temperature-controlled packaging
Patient reviews14,8209,860
eRxDoctor score8.4/107.5/10

The real cost: six months and twelve

Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.

 altRxSnagRx
First month$89$99
Months 2 onward$89/mo$99/mo
6-month total$534$594
12-month total$1,068$1,188
Best published planNo multi-month discount published12-month semaglutide plan at $69/mo ($828 a year) — $828/yr

SnagRx finishes the year $240 cheaper. For some patients the support altRx bundles closes that gap; for a patient who only needs the prescription written, it does not.

How you pay, not just what you pay

altRx accepts Affirm, Klarna and Afterpay. Buy-now-pay-later spreads the first months, which is when GLP-1 costs and side effects both peak.

SnagRx publishes no financing options, so the full monthly charge lands on a card each cycle. At $99/mo that is manageable for most people, but it removes a lever if a month gets tight.

Financing is not free money — deferred payments still arrive — but for a treatment whose costs front-load, having the option changes who can start at all.

How altRx works

altRx is the most affordable GLP-1 program, limited offer: semaglutide $89/month and tirzepatide $149/month. 100% online medical visits, no membership, insurance or hidden fees, free and discreet 2-day delivery. Against SnagRx, that puts it in the position of the cheaper option.

From signup to first shipment: 100% online medical visits, then free, discreet 2-day delivery. Billing follows a flat rate at every dose structure.

What continues after the first shipment: responsive care team for ongoing clinician-guided support. Formulary: compounded semaglutide and compounded tirzepatide.

altRx pros

  • 100% online medical visits, no clinic appointments required
  • Limited offer: semaglutide $89/mo and tirzepatide $149/mo, most affordable GLP-1 program on the market
  • No membership, insurance or hidden fees
  • Buy now, pay later with Affirm, Klarna, Afterpay

altRx cons

  • Compounded medication, not FDA-approved branded product
  • Not available in all U.S. states

The cost of choosing this over SnagRx: the rate is a limited offer and the platform does not operate in every state.

Inside the SnagRx program

SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping. What it is really selling here is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly.

You start with 5-minute intake, clinician review typically within 5 hours and always within 24; medication arrives via free next-day UPS or FedEx in temperature-controlled packaging. The price behaves as flat rate at every dose.

1:1 nursing staff plus a secure patient portal for refills and dose changes. The formulary covers compounded semaglutide and compounded tirzepatide.

SnagRx pros

  • Clinician review typically within 5 hours; next-day temperature-controlled shipping
  • Full refund if the prescription is declined, plus a 6-month weight-loss guarantee (terms apply)
  • Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
  • Price locked flat at every dose and at renewal — no re-pricing during titration

SnagRx cons

  • Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
  • The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
  • Heavy urgency marketing, including a countdown timer on the pricing page

Against altRx specifically, the trade you are making: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.

Who should choose altRx, and who should choose SnagRx

Choose altRx if:

  • the level of clinical contact suits you: responsive care team for ongoing clinician-guided support
  • you want to start on their timeline: 100% online medical visits
  • delivery works the way you want it to: free, discreet 2-day delivery
  • the monthly rate is the constraint — $89/mo against $99/mo

Choose SnagRx if:

  • you would get real value from the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly
  • the level of clinical contact suits you: 1:1 nursing staff plus a secure patient portal for refills and dose changes
  • you want the price you sign up at to survive titration
  • you are willing to commit for a term in exchange for a lower effective rate (12-month semaglutide plan at $69/mo ($828 a year))

Honest trade-offs

On price. $89/mo against $99/mo. SnagRx is asking you to pay for the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly; decide whether that is a line item you will use.

On commitment. SnagRx rewards a longer commitment (12-month semaglutide plan at $69/mo ($828 a year)), which lowers the effective rate but ties up money before you know how you respond to the medication. Financing is available through altRx (Affirm, Klarna and Afterpay).

On predictability. The pricing structures differ (flat rate at every dose versus flat rate at every dose), and structure, not headline rate, determines the twelve-month bill.

On access. altRx advertises 100% online medical visits and free, discreet 2-day delivery; SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24 and free next-day UPS or FedEx in temperature-controlled packaging. Coverage differs too — not available in every state against 48 states — which decides the question before price does if you are in a restricted state.

The medication, not the platform

Weight loss percentages quoted in telehealth marketing come from trials neither altRx nor SnagRx ran. Here is the source material, and what regulators say alongside it.

NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.

The FDA approved tirzepatide for chronic weight management in November 2023, two years after semaglutide, per FDA.

None of that settles which of these two to use. It does mean the drug is doing the work, and you are choosing who supplies it and on what terms.

altRx vs SnagRx: common questions

What happens when altRx's promotional price ends?

The rate moves to $89/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.

Which costs less over a year, altRx or SnagRx?

SnagRx, at roughly $828 for twelve months against $1,068 at altRx, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.

Is altRx cheaper than SnagRx?

Yes, on the ongoing rate. altRx runs $89/mo once promotional pricing ends, against $99/mo at SnagRx — a difference of 11%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.

Which has more patient reviews, altRx or SnagRx?

altRx, with 14,820 against 9,860. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.

Can I switch from altRx to SnagRx later?

Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge, and read the cancellation terms on any prepaid plan before you do.

Do altRx and SnagRx prescribe the same medication?

Both dispense compounded GLP-1 preparations. altRx lists compounded semaglutide and compounded tirzepatide and SnagRx lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.

What happens if I stop taking the medication?

Neither altRx nor SnagRx penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.

The verdict

Strictly on cost, SnagRx takes it — $828 to $1,068 over twelve months.

altRx earns the difference in one situation: when the cheapest published tirzepatide rate on this list at $149, with the injection kit included is something you will genuinely use. If you cannot say that out loud, take the cheaper program.

Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.

Keep comparing

See every provider in context on the weight loss rankings, or browse the full comparison index.

Disclaimers and methodology

Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.

Some links are affiliate links and may generate commission at no extra cost to you.

Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.

eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by altRx or SnagRx, and does not sell treatment. Read our ranking methodology.